Otsuka Holdings Co., Ltd. (OTSKF)
OTCMKTS
· Delayed Price · Currency is USD
47.37
-0.43 (-0.90%)
May 27, 2025, 4:00 PM EDT
Otsuka Holdings Revenue
Otsuka Holdings had revenue of 582.84B JPY in the quarter ending March 31, 2025, with 12.19% growth. This brings the company's revenue in the last twelve months to 2.39T, up 14.52% year-over-year. In the year 2024, Otsuka Holdings had annual revenue of 2.33T with 15.42% growth.
Revenue (ttm)
2,393.18B JPY
Revenue Growth
+14.52%
P/S Ratio
1.55
Revenue / Employee
67.72M JPY
Employees
35,338
Market Cap
24.73B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2,329.86B | 311.29B | 15.42% |
Dec 31, 2023 | 2,018.57B | 280.57B | 16.14% |
Dec 31, 2022 | 1,738.00B | 239.72B | 16.00% |
Dec 31, 2021 | 1,498.28B | 75.45B | 5.30% |
Dec 31, 2020 | 1,422.83B | 26.59B | 1.90% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
BioStem Technologies | 332.45M |